Pancreatic Cancer Clinical Trials

Showing 161-180 of 1,185 trials

Pancreatic Cancer Detection Consortium

NCT06388967

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Pancreatic CancerPancreatic CarcinomaPancreatic Adenocarcinoma+10 more

City of Hope Medical Center2,000 participantsStarted Mar 2023

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Monrovia, California, United States +8 more locations

RECRUITINGPhase 1

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

NCT06411691

Phase 1b study evaluating the efficacy and immune response to a synthetic long peptide mutant KRAS vaccine (SPL mKRASvax) combined with Balstilimab and Botensilimab for unresectable or metastatic mismatch repair-proficient (MMR-p) colorectal cancer (mCRC) or unresectable or metastatic MMR-p pancreatic ductal adenocarcinoma (PDAC) patients with measurable disease following first-line chemotherapy.

Colorectal CancerPancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins54 participantsStarted Jun 2025

Baltimore, Maryland, United States

Pancreatic Cancer Detection Consortium

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Related Searches

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

A Study of Multiparametric Ultrasound Imaging Methods

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Adebrelimab and Chidamide for Pancreatic Cancer

A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic Cancer

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

REVOLUTION Surgery (REVOLUTION Surgery)

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer